Search Menu Board of Directors William T. Winters Board member since 2013 Nationality: British/American | Year of birth: 1961 William T. Winters has extensive leadership experience in the financial sector. He began his career at JPMorgan Chase & Co. in 1983 and has held management roles across several market areas and in corporate finance. Mr. Winters founded Renshaw Bay LLP, an alternative asset management firm, and now serves as CEO of Standard Chartered PLC, where he is leading a digital transformation of the global bank. Professional experience CEO, Standard Chartered PLC, UK (2015–present) Chairman and CEO, Renshaw Bay LLP, UK (2011–2015) Co-CEO of the Investment Bank, JPMorgan Chase & Co., UK (2004–2010) Various managerial positions at JPMorgan Chase & Co., UK and US (1983–2004) Mandates Board member, Standard Chartered Bank PLC, UK Board member, International Rescue Committee, UK Chair of the board of trustees, The Coronet Theatre, UK Commissioner, Independent Commission on Banking, UK (2010–2011) Education Master of Business Administration, Wharton School of the University of Pennsylvania, US Bachelor’s degree in international relations, Colgate University, US Key skills Leadership/management Finance/accounting Law/regulatory/risk management Data/digital Novartis Navigate Topics Explore Companies © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience

Search Menu Share Data & Analysis Share Overview Novartis ordinary shares ISIN CH0012005267 Bloomberg symbol NOVN SW Reuters NOVN.S Currency CHF Par value 0.5 Primary exchange SIX SWISS EXCHANGE Index inclusions (selection) Swiss Market Index SMI®, Swiss Performance Index SPI®, Swiss Leader Index SLI®, STOXX® Europe 50, FTSE Eurotop 100 Index, Bloomberg European 500 Index, Dow Jones Global Titans 50 Index, S&P Global 100, MSCI World Index Novartis ADR ISIN US66987V1098 Bloomberg symbol NVS US Reuters NVS Currency USD Primary exchange NEW YORK STOCK EXCHANGE Index inclusions (selection) S&P ADR Index, NYSE Composite Index®, NYSE Arca Pharmaceutical Index, NYSE Arca International Market Index Novartis Navigate Topics Explore Companies © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience